article thumbnail

DEA Approves Cocaine Derivative for Parkinson’s Research. Why Not Cannabis?

Veriheal

But recent news of the DEA’s approval of a cocaine derivative for Parkinson’s disease research has left us scratching our heads. After receiving a petition three years prior, the DEA finally answered with action, making plans to deschedule [18F]FP-CIT , a controlled substance derived from cocaine.

DEA 98
article thumbnail

Veriheal’s Innovation in Cannabis Scholarship 2020 Winners

Veriheal

Essay Summary: Maha envisions making a positive social impact on California’s cannabis industry through patient advocacy, cannabis education, social research, and R&D. Maha was the founder and president of UCLA’s first registered cannabis student group, Cannaclub. The club now has 3,000 members nationwide. .

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Daniella Styagova: United States v. Oakland Cannabis Buyers’ Cooperative

Cannabis Law Report

Facts and Procedural History: The Controlled Substances Act was passed in 1970 and created a single legal framework for regulating substances that are thought to have a high risk of abuse and addiction. To consider the full impact of this Supreme Court decision it is necessary to delve into the history of the Controlled Substance Act.

DEA 52
article thumbnail

Minorities in cannabis, with Steven Philpott Jr.

The Cannigma

Listen & Subscribe: In light of Black History Month, we feel it is important and relevant to talk about how minorities in the United States and around the world have been disproportionately affected by drug policy and the war on drugs. EG: So, it is February, which means it’s Black History Month in the US right, Codi?

article thumbnail

AAFP ( American Academy of Family Physicians) Releases Marijuana, Cannabinoids Position Paper

Cannabis Law Report

Cannabis use, both medically and recreationally, is prevalent throughout history. Due to the Schedule I classification by the Drug Enforcement Agency (DEA), researchers seeking to investigate health effects associated with cannabis must follow a regimented application process. Background. Extensive evidence. 1 In the U.S. References.

article thumbnail

Lighting Up Florida’s Medical Marijuana People: The Medics Series, Part 6

Cannabis Law Report

Cannabis is not a “gateway” drug, according to the ASA and the DEA’s own statements cited in the August 2016 U.S. “Today, Americans for Safe Access (ASA), the leading advocacy organization dedicated to ensuring safe and legal access to cannabis (marijuana) for therapeutic use and research, and Aurelius Data , Inc.(AD),

article thumbnail

US Hemp Roundtable: Press Coverage Provides Sneak Peak Into U.S. Hemp Roundtable Virtual Fly-In

Cannabis Law Report

Many producers expressed concerns that the DEA’s interim final rule would criminalize the processing of hemp extracts. The bill would also get rid of the USDA’s requirement that only DEA laboratories can test hemp products. There are currently zero DEA registered labs in my home state and [only] one in New England,” Pingree said.

Hemp 52